Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis US FDA Form 483 Observations by Year
Novartis US FDA Form 483 Observations: 2 in FY2025, down 50.0% from a year earlier.
Latest, FY2025
2
Period ended Dec 31, 2025
Change on a year earlier
-50.0%
4 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf
Where the FY2025 figure comes from
“| Form 483 | 2 | 4”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | US FDA Form 483 Observations | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | -50.0% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 4 | – | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
Cite this data
StockData. (2026). Novartis US FDA Form 483 Observations, annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/qual-fda-form-483
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.